The Pattern of Pharmacological Treatment in Subjects with Metabolic Syndrome: Findings from Isfahan Healthy Heart Program
Background: Pharmacological therapy is a critical step in the management of individuals with Metabolic Syndrome (MetS) when lifestyle modifications can not to achieve the therapeutic goals. However, it is well-documented that other than weight loss, there is no single best therapy, and the treatment...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | fas |
| Published: |
Isfahan University of Medical Sciences
2011-07-01
|
| Series: | مجله دانشکده پزشکی اصفهان |
| Subjects: | |
| Online Access: | http://jims.mui.ac.ir/index.php/jims/article/view/1011 |
| _version_ | 1797719186702598144 |
|---|---|
| author | Mojgan Gharipour Afshan Akhavan TAbib Nafiseh Toghianifar Aliakbar Tavassoli Amin Gharipour Nizal Sarrafzadegan |
| author_facet | Mojgan Gharipour Afshan Akhavan TAbib Nafiseh Toghianifar Aliakbar Tavassoli Amin Gharipour Nizal Sarrafzadegan |
| author_sort | Mojgan Gharipour |
| collection | DOAJ |
| description | Background: Pharmacological therapy is a critical step in the management of individuals with Metabolic Syndrome (MetS) when lifestyle modifications can not to achieve the therapeutic goals.
However, it is well-documented that other than weight loss, there is no single best therapy, and the treatment should consist of treatment of individual components of the MetS. The objective of this study was to investigate treatment of individual components of the MetS among a population–based sample of individuals with the clustering of those components of the MetS.
Methods: A cross-sectional population-based study, a randomly collected sample of men and women living in three counties in central Iran participating in the baseline survey of a community –based program in 2000-2001 were examined. A questionnaire was completed for all participants to collect data regarding their demographic characteristics, medical status and history of medication use. In this study we determined the association between clustering of MetS components and pharmacological treatment of cardiovascular risk factors.
Finding: The most common pharmacologic agent received by individuals with MetS were beta blockers (72.8%) used for controlling high blood pressure, followed by lipid lowering agents (36%) without significant gender difference.
Conclusion: Our results exhibited Beta blockers, statins, fibrates and glybenclamid are more prevalent drugs among subjects with metabolic syndrome. Further research is needed to better elucidate the compliance behavior of patients who have been diagnosed with MetS. |
| first_indexed | 2024-03-12T09:02:09Z |
| format | Article |
| id | doaj.art-d5b4da47c25e46f2a8cb057ab19b5f1f |
| institution | Directory Open Access Journal |
| issn | 1027-7595 1735-854X |
| language | fas |
| last_indexed | 2024-03-12T09:02:09Z |
| publishDate | 2011-07-01 |
| publisher | Isfahan University of Medical Sciences |
| record_format | Article |
| series | مجله دانشکده پزشکی اصفهان |
| spelling | doaj.art-d5b4da47c25e46f2a8cb057ab19b5f1f2023-09-02T15:38:57ZfasIsfahan University of Medical Sciencesمجله دانشکده پزشکی اصفهان1027-75951735-854X2011-07-0129138562570673The Pattern of Pharmacological Treatment in Subjects with Metabolic Syndrome: Findings from Isfahan Healthy Heart ProgramMojgan Gharipour0Afshan Akhavan TAbib1Nafiseh Toghianifar2Aliakbar Tavassoli3Amin Gharipour4Nizal Sarrafzadegan5Researcher in Biochemistry, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, IranIsfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.Associate Professor. Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.Data mining Researcher, Isfahan Mathematics House, Isfahan, Iran.Professor, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.Background: Pharmacological therapy is a critical step in the management of individuals with Metabolic Syndrome (MetS) when lifestyle modifications can not to achieve the therapeutic goals. However, it is well-documented that other than weight loss, there is no single best therapy, and the treatment should consist of treatment of individual components of the MetS. The objective of this study was to investigate treatment of individual components of the MetS among a population–based sample of individuals with the clustering of those components of the MetS. Methods: A cross-sectional population-based study, a randomly collected sample of men and women living in three counties in central Iran participating in the baseline survey of a community –based program in 2000-2001 were examined. A questionnaire was completed for all participants to collect data regarding their demographic characteristics, medical status and history of medication use. In this study we determined the association between clustering of MetS components and pharmacological treatment of cardiovascular risk factors. Finding: The most common pharmacologic agent received by individuals with MetS were beta blockers (72.8%) used for controlling high blood pressure, followed by lipid lowering agents (36%) without significant gender difference. Conclusion: Our results exhibited Beta blockers, statins, fibrates and glybenclamid are more prevalent drugs among subjects with metabolic syndrome. Further research is needed to better elucidate the compliance behavior of patients who have been diagnosed with MetS.http://jims.mui.ac.ir/index.php/jims/article/view/1011Metabolic syndromeIranPharmacological treatment |
| spellingShingle | Mojgan Gharipour Afshan Akhavan TAbib Nafiseh Toghianifar Aliakbar Tavassoli Amin Gharipour Nizal Sarrafzadegan The Pattern of Pharmacological Treatment in Subjects with Metabolic Syndrome: Findings from Isfahan Healthy Heart Program مجله دانشکده پزشکی اصفهان Metabolic syndrome Iran Pharmacological treatment |
| title | The Pattern of Pharmacological Treatment in Subjects with Metabolic Syndrome: Findings from Isfahan Healthy Heart Program |
| title_full | The Pattern of Pharmacological Treatment in Subjects with Metabolic Syndrome: Findings from Isfahan Healthy Heart Program |
| title_fullStr | The Pattern of Pharmacological Treatment in Subjects with Metabolic Syndrome: Findings from Isfahan Healthy Heart Program |
| title_full_unstemmed | The Pattern of Pharmacological Treatment in Subjects with Metabolic Syndrome: Findings from Isfahan Healthy Heart Program |
| title_short | The Pattern of Pharmacological Treatment in Subjects with Metabolic Syndrome: Findings from Isfahan Healthy Heart Program |
| title_sort | pattern of pharmacological treatment in subjects with metabolic syndrome findings from isfahan healthy heart program |
| topic | Metabolic syndrome Iran Pharmacological treatment |
| url | http://jims.mui.ac.ir/index.php/jims/article/view/1011 |
| work_keys_str_mv | AT mojgangharipour thepatternofpharmacologicaltreatmentinsubjectswithmetabolicsyndromefindingsfromisfahanhealthyheartprogram AT afshanakhavantabib thepatternofpharmacologicaltreatmentinsubjectswithmetabolicsyndromefindingsfromisfahanhealthyheartprogram AT nafisehtoghianifar thepatternofpharmacologicaltreatmentinsubjectswithmetabolicsyndromefindingsfromisfahanhealthyheartprogram AT aliakbartavassoli thepatternofpharmacologicaltreatmentinsubjectswithmetabolicsyndromefindingsfromisfahanhealthyheartprogram AT amingharipour thepatternofpharmacologicaltreatmentinsubjectswithmetabolicsyndromefindingsfromisfahanhealthyheartprogram AT nizalsarrafzadegan thepatternofpharmacologicaltreatmentinsubjectswithmetabolicsyndromefindingsfromisfahanhealthyheartprogram AT mojgangharipour patternofpharmacologicaltreatmentinsubjectswithmetabolicsyndromefindingsfromisfahanhealthyheartprogram AT afshanakhavantabib patternofpharmacologicaltreatmentinsubjectswithmetabolicsyndromefindingsfromisfahanhealthyheartprogram AT nafisehtoghianifar patternofpharmacologicaltreatmentinsubjectswithmetabolicsyndromefindingsfromisfahanhealthyheartprogram AT aliakbartavassoli patternofpharmacologicaltreatmentinsubjectswithmetabolicsyndromefindingsfromisfahanhealthyheartprogram AT amingharipour patternofpharmacologicaltreatmentinsubjectswithmetabolicsyndromefindingsfromisfahanhealthyheartprogram AT nizalsarrafzadegan patternofpharmacologicaltreatmentinsubjectswithmetabolicsyndromefindingsfromisfahanhealthyheartprogram |